دورية أكاديمية

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

التفاصيل البيبلوغرافية
العنوان: Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
المؤلفون: Vithayathil, Mathew, D’Alessio, AntonioAff1, Aff2, Fulgenzi, Claudia Angela MariaAff1, Aff3, Nishida, Naoshi, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Saeed, Anwaar, Wietharn, Brooke, Hildebrand, Hannah, Wu, Linda, Ang, Celina, Marron, Thomas U., Weinmann, Arndt, Galle, Peter R., Bettinger, Dominik, Bengsch, BertramAff10, Aff11, Aff12, Vogel, Arndt, Balcar, Lorenz, Scheiner, Bernhard, Lee, Pei-Chang, Huang, Yi-HsiangAff15, Aff16, Amara, Suneetha, Muzaffar, Mahvish, Naqash, Abdul RafehAff17, Aff18, Cammarota, AntonellaAff2, Aff19, Zanuso, ValentinaAff2, Aff19, Pressiani, Tiziana, Pinter, Matthias, Cortellini, Alessio, Kudo, Masatoshi, Rimassa, LorenzaAff2, Aff19, Pinato, David J.Aff1, Aff20, Sharma, RohiniAff1, IDs12072023104913_cor35
المصدر: Hepatology International. 17(4):904-914
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:19360533
19360541
DOI:10.1007/s12072-023-10491-3